Cite

HARVARD Citation

    Sitbon, O. et al. (2019). Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial. Lancet. 7 (7), pp. 594-604. [Online]. 
  
Back to record